-+ 0.00%
-+ 0.00%
-+ 0.00%

HBM9378/WIN378, AN ULTRA-LONG-ACTING ANTIBODY TARGETING TSLP, ACHIEVES POSITIVE PHASE 2 RESULTS IN ASTHMA AND INITIATES PHASE 3 STUDY

Reuters·09/08/2026 12:17:28

Please log in to view news